Related Experiment Videos
Ocular timolol levels after drug withdrawal: an experimental model
Summary
Carbon 14-labelled timolol maleate, a glaucoma medication, concentrates in pigmented ocular tissues and releases slowly. Even 42 days post-withdrawal, timolol was detected, explaining its long-term effects on aqueous production.
Area of Science:
- Ophthalmology
- Pharmacology
- Ocular Toxicology
Background:
- Topical timolol maleate is a common treatment for glaucoma.
- Understanding the ocular tissue distribution and retention of timolol is crucial for optimizing its therapeutic efficacy and minimizing side effects.
Purpose of the Study:
- To investigate the ocular tissue distribution and long-term retention of carbon 14-labelled timolol maleate in pigmented rabbits following repeated topical administration.
Main Methods:
- Carbon 14-labelled timolol maleate was administered daily to the eyes of 12 pigmented rabbits for 42 days.
- Ocular tissues and aqueous humor drug levels were quantified up to 42 days after cessation of treatment.
Main Results:
- Timolol maleate demonstrated significant concentration in melanotic ocular tissues.
- Slow drug release was observed, with detectable levels in pigmented tissues persisting for 42 days post-withdrawal.
- Timolol was present in the aqueous humor for up to 5 days after drug withdrawal.
Conclusions:
- The prolonged presence of timolol in ocular tissues, particularly melanotic ones, contributes to its long-term ocular hypotensive effect.
- Findings suggest that the dosage or frequency of topical timolol maleate may need adjustment in glaucoma patients, especially those with significant pigmentation.